Skip to main content

Table 2 Summary of T-MPs served as therapeutic tumor vaccines

From: Application of tumor microparticles in tumor prevention and treatment

Administration

Activated immunocytes

Treated tumors

References

i.v.

DCs, T cells

s.c. H22, CT26

(Zhang et al. 2015)

i.v.

Monocytes, T cells

i.m. H22, B16; Metastatic B16-OVA

(Sun et al. 2023)

Intrapleural

Macrophages, T cells

LLC with MPE

(Wan et al. 2020)

s.c

T cells

s.c. C6

(Pineda et al. 2019)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us